ENvue Medical, Inc. (FEED) Stock

ENvue Medical, Inc. (FEED) is a Healthcare stock trading at $0.68 (as of 2026-06-18), with a market capitalization of $3.03M and a trailing P/E of -0.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

NanoVibronix, Inc. develops noninvasive devices intended to activate biological responses, including UroShield and PainShield. The company operates in the United States, Europe, Australia, India, Israel, and other regions.

Valuation — source: SEC EDGAR (first-party)
Price$0.68
Market Cap$3.03M
P/E Ratio-0.0
EV / EBITDA-0.1
Price / Book0.13
Price / Sales1.88
DCF Value (model)$-42.24
DCF Upside vs Price-6315.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$2.55M
Net Margin-712.3%
Return on Equity-60.9%
Debt / Equity0.04
Current Ratio0.90
Revenue Growth (YoY)-36.3%
EPS Growth (YoY)-77.0%
FCF Growth (YoY)221.1%
Financial Health — source: SEC EDGAR
Altman Z-Score-4.64 (distress)
Valuation vs Sector & Industry
Stock P/E-0.0
Sector P/E (Healthcare)20.9
Industry P/E (Medical Equipment)31.7
vs Sector-100.1%
vs Industry-100.1%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderGEODE CAPITAL MANAGEMENT, LLC ($53352.00)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEODoron Robert Besser
Employees31
CountryUS
IPO Date2025-12-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Innovative Eyewear, Inc. (LUCY)
  • HeartSciences Inc. (HSCS)
  • Sonoma Pharmaceuticals, Inc. (SNOA)
  • Nuwellis, Inc. (NUWE)
  • Bone Biologics Corporation (BBLG)
  • SeaStar Medical Holding Corporation (ICU)
  • Lifeward Ltd. (LFWD)
  • Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist (AEMD)
FEED earnings history · FEED institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.